Key points are not available for this paper at this time.
Phosphine and bidentate N−N ligands inhibit the Alder-ene-type cycloisomerization of enynes catalyzed by Pt(II) and favor the alkoxycyclization process. The enantioselective Pt(II)-catalyzed alkoxycyclization has been studied in the presence of chiral mono- and bidentate phosphines, as well as chiral bidentate N−N ligands. Modest levels of enantioselection (up to 50% ee) have been obtained with Tol-BINAP as ligand. The alkoxycyclizations with a catalyst formed from Au(L)Cl/AgX proceed more readily, and up to 94% ee's have been obtained using (AuCl) 2 (Tol-BINAP) ( 47 ) as the precatalyst. The X-ray crystal structures of Au(I) complexes 47 and chloro-( R )-2-( tert -butylsulfenyl)-1-(diphenylphosphino)ferrocene gold(I) ( 39 ) show the AuCl fragments monocoordinated with the P centers of the chiral phosphine ligands.
Muñoz et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: